(Q39210882)

English

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

scientific article published on 14 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine (English)

1 reference

Europe PubMed Central

10 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Y Xiang

1

1 reference

Europe PubMed Central

10 September 2017

N Ma

2

1 reference

Europe PubMed Central

10 September 2017

D Wang

3

1 reference

Europe PubMed Central

10 September 2017

Y Zhang

4

1 reference

Europe PubMed Central

10 September 2017

J Zhou

5

1 reference

Europe PubMed Central

10 September 2017

G Wu

6

1 reference

Europe PubMed Central

10 September 2017

R Zhao

7

1 reference

Europe PubMed Central

10 September 2017

H Huang

8

1 reference

Europe PubMed Central

10 September 2017

X Wang

9

1 reference

Europe PubMed Central

10 September 2017

Y Qiao

10

1 reference

Europe PubMed Central

10 September 2017

F Li

11

1 reference

Europe PubMed Central

10 September 2017

D Han

12

1 reference

Europe PubMed Central

10 September 2017

L Wang

13

1 reference

Europe PubMed Central

10 September 2017

G Zhang

14

1 reference

Europe PubMed Central

10 September 2017

X Gao

15

1 reference

Europe PubMed Central

10 September 2017

language of work or name

0 references

publication date

14 January 2013

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

33

1 reference

Europe PubMed Central

10 September 2017

3

1 reference

Europe PubMed Central

10 September 2017

378-386

1 reference

Europe PubMed Central

10 September 2017

https://scigraph.springernature.com/pub.10.1038/onc.2012.575

0 references

A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Optimal chemotherapy treatment for women with recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Utility of DNA methyltransferase inhibitors for the treatment of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenetic resensitization to platinum in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Decitabine dosing schedules.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MicroRNAs in cardiomyocyte development

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Cisplatin: a review of toxicities and therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

The resurgence of platinum-based cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

DNA repair pathways as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenetic regulation of cancer-associated genes in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

The epigenomics of cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Autoregulatory suppression of c-Myc by miR-185-3p

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenetics as a mechanism driving polygenic clinical drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

Epigenomics of ovarian cancer and its chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

31 March 2020

Cellular responses to Cisplatin-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.575

31 March 2020

Identifiers

10.1038/ONC.2012.575

1 reference

Europe PubMed Central

10 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39210882&oldid=1813127584"